Barriers and facilitators of adherence to anti-TB treatment in Western Indian population: A cross-sectional study [0.03%]
印度西部人口抗结核治疗依从性的障碍与促进因素：横断面研究
Richa Gwalani,Harsh Shah,Deepak Saxena et al.
Richa Gwalani et al.
Introduction: Achieving successful treatment outcomes for tuberculosis (TB) is essential in reaching the End TB goals. However, adherence to anti-TB treatment remains a significant challenge, leading to poor treatment out...
Sociodemographic profile in households of pulmonary tuberculosis patients: A six- year longitudinal analysis [0.03%]
结核病患者家庭的社会人口学特征六年的纵向分析
Purnima Tadingi,Komala Ezhumalai,Senbagavalli Prakash Babu et al.
Purnima Tadingi et al.
Background: Tuberculosis (TB) remains a foremost public health concern in India, disproportionately affecting disadvantaged socioeconomic groups and amplifying poverty and inequality. This study explores longitudinal chan...
Spatial distribution and temporal dynamics of drug-susceptible and drug-resistant Mycobacterium tuberculosis in a referral centre in Ibadan [0.03%]
伊巴丹转诊中心药物敏感和耐药结核分枝杆菌的时空分布及动态变化模式分析
Pelumi Daniel Adewole,Olumuyiwa Samuel Alabi
Pelumi Daniel Adewole
Background/aims: This study examines the seasonal and spatial distribution of drug-susceptible (DS-TB) and drug-resistant (DR-TB) tuberculosis at a referral centre in Ibadan. ...
Development of home-based malnutrition management tool for patients with tuberculosis [0.03%]
居家治疗的结核病患者营养状况管理工具的研发
Anjani Bakshi,Neha Bakshi,Neena Bhatia
Anjani Bakshi
Background: Mortality remains high among undernourished patients with tuberculosis (PwTB). This study aims to improve the utilization of "Nikshay Poshan Yojana" by providing a reference tool for PwTB and their household c...
Street women empowered and engaged to stop TB: A 'mixed method' study [0.03%]
街头女性赋权行动以阻止结核病的发生：“定性与定量相结合”的研究方法
Joyce Felicia Vaghela,Lisbeth Aarup,Ravinder Kumar et al.
Joyce Felicia Vaghela et al.
Background: The Census of India 2011 defines 'houseless household' as, "households who do not live in buildings or census houses but live in the open on roadside, pavements, under flyovers and staircases, or in the open i...
Burden and trend of drug resistant tuberculosis: Is the onus on isoniazid monoresistant TB now? [0.03%]
药物耐受结核病的负担和趋势：是否应对异烟肼单耐药结核病给予更多重视？
Vikram Sethi,Aarti Kotwal,Varuna Jethani et al.
Vikram Sethi et al.
Background: Diagnostic algorithm, till last decade have contravened the center principle of End TB Strategy. Isoniazid monoresistance (IMR) has been denied attention, most probably due to dearth of molecular diagnostic fa...
Challenges in the implementation of tuberculosis contact screening and tuberculosis preventive therapy in the paediatric age group in rural South India [0.03%]
印度南部农村地区儿科结核病接触筛查和预防治疗实施的挑战
K Dinendraram,K Koteswararao,S Somasekhararao et al.
K Dinendraram et al.
Introduction: Tuberculosis remains a major cause of morbidity and death from infectious diseases in children of all ages globally, particularly in young children. In India, childhood Tuberculosis is a staggering problem, ...
Association of treatment interruption with sputum conversion and outcomes in drug-sensitive and drug-resistant tuberculosis patients enrolled under NTEP-a prospective study from 3 centers in South Delhi, Delhi, India [0.03%]
治疗中断与印度新德里三所中心NTEP登记的敏感和耐药结核病患者痰菌转阴及结局的关系：一项前瞻性研究
Lokender Kumar,Santosh Kumar,Vikram Vohra et al.
Lokender Kumar et al.
Background and objectives: Interruption of treatment is a vital challenge which threatens successful tuberculosis (TB) control. We studied the association of interruption patterns with sputum conversion and outcome in a c...
Observational Study
The Indian journal of tuberculosis. 2026 Apr;73(2):170-175. DOI:10.1016/j.ijtb.2025.06.006 2026
Nibedita Rath,V K Arora
Nibedita Rath
Artificial intelligence (AI) is rapidly transforming tuberculosis (TB) drug discovery by addressing major limitations of traditional pipelines, such as prolonged timelines, excessive cost, and challenges imposed by the biology of Mycobacter...
Preclinical approaches in tuberculosis drug development research: Bridging experimental tools and clinical translation [0.03%]
结核病药物研发中的临床前期研究：实验工具与临床转化之间的桥梁
Akriti Gaurav,Saif Hameed,Amit Kumar Singh et al.
Akriti Gaurav et al.
Background: Tuberculosis (TB), caused by Mycobacterium tuberculosis, continues to pose a serious global health threat, especially with the rise of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. Pr...